$TRNO
Terreno Realty Corp Stock $trno

$trno Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000147615023000014 Filed on November 01, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$86.48M	$82.92M
YoY Change	13.78%	17.12%
Cost Of Revenue	$21.65M	$20.47M
YoY Change	13.45%	19.42%
Gross Profit	$64.83M	$62.45M
YoY Change	13.9%	16.38%
Gross Profit Margin	74.97%	75.31%
Selling, General & Admin	$9.730M	$9.119M
YoY Change	18.76%	12.03%
% of Gross Profit	15.01%	14.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$18.58M	$18.25M
YoY Change	0.11%	7.96%
% of Gross Profit	28.66%	29.21%
Operating Expenses	$28.31M	$27.36M
YoY Change	5.93%	9.06%
Operating Profit	$36.52M	$35.09M
YoY Change	20.95%	22.81%
Interest Expense	-$4.772M	$5.814M
YoY Change	-32.4%	-7.2%
% of Operating Profit	-13.07%	16.57%
Other Income/Expense, Net		-$4.721M
YoY Change		-22.48%
Pretax Income	$57.56M	$30.32M
YoY Change	-2.25%	35.09%
Income Tax
% Of Pretax Income
Net Earnings	$57.28M	$30.32M
YoY Change	-2.26%	35.1%
Net Earnings / Revenue	66.23%	36.56%
Basic Earnings Per Share		$0.36
Diluted Earnings Per Share	$0.67	$0.36
COMMON SHARES
Basic Shares Outstanding	85.39M shares	83.91M shares
Diluted Shares Outstanding		84.27M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$165.4M	$96.20M
YoY Change	526.68%	843.1%
Cash & Equivalents	$165.4M	$96.20M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$165.4M	$96.20M
YoY Change	526.68%	843.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.663B	$3.560B
YoY Change	19.13%	17.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$836.0K	$11.29M
YoY Change	-50.53%	2.65%
Total Long-Term Assets	$3.739B	$3.643B
YoY Change	19.16%	17.58%
TOTAL ASSETS
Total Short-Term Assets	$165.4M	$96.20M
Total Long-Term Assets	$3.739B	$3.643B
Total Assets	$3.905B	$3.739B
YoY Change	23.39%	20.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$61.78M	$72.97M
YoY Change	24.33%	26.24%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$133.8M	$144.0M
YoY Change	23.98%	24.64%
LONG-TERM LIABILITIES
Long-Term Debt	$771.6M	$771.4M
YoY Change	0.1%	-1.18%
Other Long-Term Liabilities	$84.72M	$87.18M
YoY Change	51.63%	44.1%
Total Long-Term Liabilities	$856.3M	$858.5M
YoY Change	3.58%	2.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$133.8M	$144.0M
Total Long-Term Liabilities	$856.3M	$858.5M
Total Liabilities	$990.1M	$1.002B
YoY Change	5.93%	4.8%
SHAREHOLDERS EQUITY
Retained Earnings	$95.58M	$77.07M
YoY Change	8.28%	28.15%
Common Stock	$2.851B	$2.692B
YoY Change	31.49%	27.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.915B	$2.737B
YoY Change
Total Liabilities & Shareholders Equity	$3.905B	$3.739B
YoY Change	23.39%	20.29%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$57.28M	$30.32M
YoY Change	-2.26%	35.1%
Depreciation, Depletion And Amortization	$18.58M	$18.25M
YoY Change	0.11%	7.96%
Cash From Operating Activities	$39.05M	$53.26M
YoY Change	14.15%	16.29%
INVESTING ACTIVITIES
Capital Expenditures	$64.91M	$58.74M
YoY Change	294.59%	-318.35%
Acquisitions
YoY Change
Other Investing Activities	-$25.84M	-$14.41M
YoY Change	248.64%	-78.78%
Cash From Investing Activities	-$90.75M	-$73.15M
YoY Change	280.32%	-22.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	117.7M	60.08M
YoY Change	1648.05%	21.14%
NET CHANGE
Cash From Operating Activities	39.05M	53.26M
Cash From Investing Activities	-90.75M	-73.15M
Cash From Financing Activities	117.7M	60.08M
Net Change In Cash	66.01M	40.20M
YoY Change	286.45%	5643.0%
FREE CASH FLOW
Cash From Operating Activities	$39.05M	$53.26M
Capital Expenditures	$64.91M	$58.74M
Free Cash Flow	-$25.86M	-$5.473M
YoY Change	-245.57%	-107.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Interest Expense InterestExpense	5814000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	6265000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	93463000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	93463000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	22332000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	22332000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2599872000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	40254000	usd
CY2023Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	822000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	37903000	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	105000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3805000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.40
CY2023Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	33465000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2648264000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	30315000	usd
CY2023Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1438000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	94309000	usd
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	773000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3280000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.45
CY2023Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	38425000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2736970000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2057963000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	19662000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	493000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2829000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.34
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	25680000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	2054281000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	97033000	usd
CY2022Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	112000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1947000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2010000	usd
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.34
CY2022Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	25686000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2129585000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	22439000	usd
CY2022Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	548000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	28335000	usd
CY2022Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	518000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2679000	usd
CY2022Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.40
CY2022Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	30427000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	2152093000	usd
	us-gaap	Net Income Loss NetIncomeLoss	93900000	usd
	us-gaap	Net Income Loss NetIncomeLoss	139134000	usd
	us-gaap	Straight Line Rent StraightLineRent	6510000	usd
	us-gaap	Straight Line Rent StraightLineRent	7326000	usd
	trno	Amortization Of Lease Intangibles AmortizationOfLeaseIntangibles	10681000	usd
	trno	Amortization Of Lease Intangibles AmortizationOfLeaseIntangibles	10807000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	54636000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	47227000	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	12257000	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	76048000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1157000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	988000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10123000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	7518000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4447000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-543000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	14705000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7790000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	140626000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	109019000	usd
	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	392503000	usd
	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	344833000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	24585000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	106835000	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	72449000	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	24978000	usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	39270000	usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	50827000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-479637000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-313803000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	512902000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	30941000	usd
	trno	Issuance Costs On Issuance Of Common Stock IssuanceCostsOnIssuanceOfCommonStock	2740000	usd
	trno	Issuance Costs On Issuance Of Common Stock IssuanceCostsOnIssuanceOfCommonStock	468000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1505000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1011000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	49000000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	162000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	49000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	152000000	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	100000000	usd
	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0	usd
	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	50000000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	80000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1498000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	97427000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	76984000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	411150000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10980000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	72139000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-193804000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28083000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	204801000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	100222000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10997000	usd
	us-gaap	Interest Paid Net InterestPaidNet	24156000	usd
	us-gaap	Interest Paid Net InterestPaidNet	19572000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	29441000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	22861000	usd
	us-gaap	Stock Issued1 StockIssued1	5672000	usd
	us-gaap	Stock Issued1 StockIssued1	11785000	usd
	trno	Reconciliation Acquisition Of Properties ReconciliationAcquisitionOfProperties	436980000	usd
	trno	Reconciliation Acquisition Of Properties ReconciliationAcquisitionOfProperties	360818000	usd
	trno	Assumptions Of Other Assets And Liabilities AssumptionsOfOtherAssetsAndLiabilities	44477000	usd
	trno	Assumptions Of Other Assets And Liabilities AssumptionsOfOtherAssetsAndLiabilities	15985000	usd
	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	392503000	usd
	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	344833000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	6	segment
	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of the interim consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.</span>
	us-gaap	Amortization Of Above And Below Market Leases AmortizationOfAboveAndBelowMarketLeases	10800000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P6Y9M18D
CY2023Q3	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	136238000	usd
CY2023Q3	us-gaap	Below Market Lease Accumulated Amortization BelowMarketLeaseAccumulatedAmortization	49057000	usd
CY2023Q3	us-gaap	Below Market Lease Net BelowMarketLeaseNet	87181000	usd
CY2022Q4	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	95638000	usd
CY2022Q4	us-gaap	Below Market Lease Accumulated Amortization BelowMarketLeaseAccumulatedAmortization	39765000	usd
CY2022Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	55873000	usd
CY2023Q3	trno	Finite Lived Intangible Assets Liabilities Gross FiniteLivedIntangibleAssetsLiabilitiesGross	3260000	usd
CY2023Q3	trno	Finite Lived Intangible Assets Liabilities Accumulated Amortization FiniteLivedIntangibleAssetsLiabilitiesAccumulatedAmortization	46338000	usd
CY2023Q3	trno	Finite Lived Intangible Assets Liabilities Net FiniteLivedIntangibleAssetsLiabilitiesNet	-43078000	usd
CY2022Q4	trno	Finite Lived Intangible Assets Liabilities Gross FiniteLivedIntangibleAssetsLiabilitiesGross	27907000	usd
CY2022Q4	trno	Finite Lived Intangible Assets Liabilities Accumulated Amortization FiniteLivedIntangibleAssetsLiabilitiesAccumulatedAmortization	47015000	usd
CY2022Q4	trno	Finite Lived Intangible Assets Liabilities Net FiniteLivedIntangibleAssetsLiabilitiesNet	-19108000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	204801000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	204404000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	397000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10153000	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	844000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10997000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-193804000	usd
CY2022Q4	trno	Straight Line Rent And Accounts Receivables Net Of Allowances StraightLineRentAndAccountsReceivablesNetOfAllowances	48000000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	600000	usd
CY2022Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	11900000	usd
	trno	Share Based Compensation Performance Measurement Period ShareBasedCompensationPerformanceMeasurementPeriod	P3Y
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	2600000	usd
CY2022Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	600000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	5500000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	2200000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	775000000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	775000000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	775000000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	775000000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	3645000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	4182000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	771355000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	770818000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	100000000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	50000000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	150000000	usd
CY2023Q3	trno	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	475000000	usd
CY2023Q3	trno	Long Term Debt Before Net Debt Issuance Costs LongTermDebtBeforeNetDebtIssuanceCosts	775000000	usd
CY2023Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3645000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	771355000	usd
CY2023Q3	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.040
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	60005000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	241049000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	224558000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	190944000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	144295000	usd
CY2023Q3	trno	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	342267000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1203118000	usd
CY2023Q3	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	695712000	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	771355000	usd
CY2022Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	700926000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	770818000	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q3	trno	Sales Of Stock Weighted Average Offering Price SalesOfStockWeightedAverageOfferingPrice	60.78
	trno	Sales Of Stock Weighted Average Offering Price SalesOfStockWeightedAverageOfferingPrice	61.61
CY2023Q3	trno	Fees And Commissions At Market Equity Offering Program Sales Agent FeesAndCommissionsAtMarketEquityOfferingProgramSalesAgent	1400000	usd
	trno	Fees And Commissions At Market Equity Offering Program Sales Agent FeesAndCommissionsAtMarketEquityOfferingProgramSalesAgent	2300000	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	444512	shares
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	471599	shares
CY2022Q3	trno	Sales Of Stock Weighted Average Offering Price SalesOfStockWeightedAverageOfferingPrice	64.97
	trno	Sales Of Stock Weighted Average Offering Price SalesOfStockWeightedAverageOfferingPrice	65.61
CY2023Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	3000000	shares
	trno	Stock Withdrawn During Period From Deferred Compensation Plan StockWithdrawnDuringPeriodFromDeferredCompensationPlan	0	shares
CY2023Q3	trno	Stock Withdrawn During Period From Deferred Compensation Plan StockWithdrawnDuringPeriodFromDeferredCompensationPlan	0	shares
CY2022Q3	trno	Stock Withdrawn During Period From Deferred Compensation Plan StockWithdrawnDuringPeriodFromDeferredCompensationPlan	0	shares
	trno	Stock Withdrawn During Period From Deferred Compensation Plan StockWithdrawnDuringPeriodFromDeferredCompensationPlan	0	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	419500	shares
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.40
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.40
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.45
CY2023Q3	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	404010	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	335038	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	384239	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	311432	shares
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
trno-20230930_cal.xml	Edgar Link	unprocessable
trno-20230930_def.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
0001476150-23-000014-index-headers.html	Edgar Link	pending
0001476150-23-000014-index.html	Edgar Link	pending
0001476150-23-000014.txt	Edgar Link	pending
0001476150-23-000014-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trno-20230930.htm	Edgar Link	pending
trno-20230930.xsd	Edgar Link	pending
trnoq32023ex-311.htm	Edgar Link	pending
trnoq32023ex-312.htm	Edgar Link	pending
trnoq32023ex-313.htm	Edgar Link	pending
trnoq32023ex-321.htm	Edgar Link	pending
trnoq32023ex-322.htm	Edgar Link	pending
trno-20230930_lab.xml	Edgar Link	unprocessable
trno-20230930_pre.xml	Edgar Link	unprocessable
trno-20230930_htm.xml	Edgar Link	completed
trnoq32023ex-323.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TRNO
Terreno Realty Corp Stock $trno

2023 Q4 Form 10-Q Financial Statement

#000147615023000014 Filed on November 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRNO Terreno Realty Corp Stock $trno

2023 Q4 Form 10-Q Financial Statement

#000147615023000014 Filed on November 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRNO
Terreno Realty Corp Stock $trno